Advertisement

Topics

Teva Pharmaceutical Industries Limited (TEVA) Receives Neutral Rating from Mizuho

06:03 EDT 23 Aug 2017 | Topix

The firm currently has a $16.00 price target on the stock, down from their prior price target of $30.00. Other equities research analysts have also issued reports about the stock.

Original Article: Teva Pharmaceutical Industries Limited (TEVA) Receives Neutral Rating from Mizuho

NEXT ARTICLE

More From BioPortfolio on "Teva Pharmaceutical Industries Limited (TEVA) Receives Neutral Rating from Mizuho"

Advertisement
Quick Search
Advertisement
Advertisement